BRPI0820765A2 - Métodos para a produção de um peptídeo insulinotrópico e peptídeos - Google Patents
Métodos para a produção de um peptídeo insulinotrópico e peptídeosInfo
- Publication number
- BRPI0820765A2 BRPI0820765A2 BRPI0820765-8A BRPI0820765A BRPI0820765A2 BR PI0820765 A2 BRPI0820765 A2 BR PI0820765A2 BR PI0820765 A BRPI0820765 A BR PI0820765A BR PI0820765 A2 BRPI0820765 A2 BR PI0820765A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- producing
- methods
- insulinotropic peptide
- insulinotropic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US723807P | 2007-12-11 | 2007-12-11 | |
PCT/EP2008/066585 WO2009074483A2 (en) | 2007-12-11 | 2008-12-02 | Insulinotropic peptide synthesis using solid and solution phase combination techniques |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0820765A2 true BRPI0820765A2 (pt) | 2015-06-16 |
Family
ID=40755926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0820765-8A BRPI0820765A2 (pt) | 2007-12-11 | 2008-12-02 | Métodos para a produção de um peptídeo insulinotrópico e peptídeos |
Country Status (17)
Country | Link |
---|---|
US (1) | US8227571B2 (pt) |
EP (1) | EP2222695A2 (pt) |
JP (1) | JP2011506376A (pt) |
KR (1) | KR20100102652A (pt) |
CN (1) | CN101903400B (pt) |
AR (1) | AR069608A1 (pt) |
AU (1) | AU2008334783A1 (pt) |
BR (1) | BRPI0820765A2 (pt) |
CA (1) | CA2707132A1 (pt) |
CL (1) | CL2008003660A1 (pt) |
IL (1) | IL205932A0 (pt) |
MX (1) | MX2010006044A (pt) |
PE (1) | PE20091214A1 (pt) |
RU (1) | RU2010128247A (pt) |
TW (1) | TWI374890B (pt) |
WO (1) | WO2009074483A2 (pt) |
ZA (1) | ZA201003849B (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2344519T3 (en) * | 2008-11-07 | 2017-01-23 | Massachusetts Gen Hospital | C-TERMINAL FRAGMENTS OF GLUCAGON SIMILAR PEPTID-1 (GLP-1) |
EP2424888A2 (en) * | 2009-05-01 | 2012-03-07 | F. Hoffmann-La Roche AG | Insulinotropic peptide synthesis using solid and solution phase combination techniques |
US20110313131A1 (en) | 2010-06-21 | 2011-12-22 | Christelle Carl | Reversed phase hplc purification of a glp-1 analogue |
US20120157382A1 (en) | 2010-12-21 | 2012-06-21 | Siegfried Krimmer | Pharmaceutical glp-1 compositions having an improved release profile |
EP3412680B1 (en) | 2011-04-05 | 2020-11-04 | Curara AB | Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment |
EP2729157B1 (en) | 2011-07-06 | 2019-01-16 | The General Hospital Corporation | A pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) for use in treatment |
CN104936610A (zh) | 2012-11-13 | 2015-09-23 | 益普生制药股份有限公司 | Glp-1类似物的纯化方法 |
WO2014077801A1 (en) | 2012-11-13 | 2014-05-22 | Ipsen Pharma S.A.S. | Purification process for preparing highly pure taspoglutide |
EP2948468A1 (en) | 2013-01-28 | 2015-12-02 | Solae, LLC | Novel polypeptides having satiety hormone releasing activity |
ES2624961T3 (es) | 2013-03-21 | 2017-07-18 | Sanofi-Aventis Deutschland Gmbh | Síntesis de productos de péptido que contienen imida cíclica |
US10087221B2 (en) | 2013-03-21 | 2018-10-02 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
GR20140100479A (el) * | 2014-09-23 | 2016-05-05 | Novetide, Ltd., | Συνθεση λιραγλουτιδης |
EP3692056A1 (en) * | 2017-10-04 | 2020-08-12 | Chemical & Biopharmaceutical Laboratories of Patras S.A. | A process for preparing a glucagon-like peptide |
KR20200001546A (ko) * | 2018-06-27 | 2020-01-06 | 주식회사 시선바이오머티리얼스 | Pna 올리고머의 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324348C (en) * | 1998-03-23 | 2006-03-14 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
CZ295890B6 (cs) * | 1998-12-07 | 2005-11-16 | Societe De Conseils De Recherches Et D'application | Analogy GLP-1, mající kyselinu aminoizomáselnou pozici 8 a D-arginin na pozici 36, jejich použití a farmaceutické prostředky je obsahující |
US6469136B1 (en) * | 1999-07-07 | 2002-10-22 | Trimeris, Inc. | Methods and composition for peptide synthesis |
CN1918177A (zh) * | 2003-12-18 | 2007-02-21 | 诺和诺德公司 | 新型glp-1化合物 |
WO2005066207A1 (en) * | 2004-01-08 | 2005-07-21 | Theratechnologies Inc. | Glucagon-like peptide-1 analogs with long duration of action |
MX2007007917A (es) * | 2004-12-30 | 2007-08-14 | Hoffmann La Roche | Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios. |
CA2593866C (en) * | 2004-12-30 | 2013-08-06 | F. Hoffmann-La Roche Ag | Synthesis of peptide t-1249 using peptide intermediate fragments |
KR20070111463A (ko) * | 2004-12-30 | 2007-11-21 | 에프. 호프만-라 로슈 아게 | 펩타이드 중간체 단편 ⅲ을 사용하는 합성 방법 |
EP1891106A2 (en) * | 2005-05-05 | 2008-02-27 | Cadila Healthcare Ltd. | Novel compounds as glp-i agonists |
KR101297942B1 (ko) * | 2006-02-08 | 2013-08-19 | 론자 아게 | 글루카곤형 펩티드의 합성 |
PT2035451E (pt) * | 2006-06-23 | 2010-06-09 | Hoffmann La Roche | Síntese de péptidos insulinotrópicos |
EP2205624B1 (en) * | 2007-10-27 | 2016-09-07 | Corden Pharma Colorado, Inc. | Insulinotropic peptide synthesis using solid and solution phase combination techniques |
-
2008
- 2008-12-02 EP EP08860359A patent/EP2222695A2/en not_active Withdrawn
- 2008-12-02 RU RU2010128247/10A patent/RU2010128247A/ru not_active Application Discontinuation
- 2008-12-02 MX MX2010006044A patent/MX2010006044A/es active IP Right Grant
- 2008-12-02 AU AU2008334783A patent/AU2008334783A1/en not_active Abandoned
- 2008-12-02 KR KR1020107015264A patent/KR20100102652A/ko active IP Right Grant
- 2008-12-02 WO PCT/EP2008/066585 patent/WO2009074483A2/en active Application Filing
- 2008-12-02 CN CN2008801198008A patent/CN101903400B/zh not_active Expired - Fee Related
- 2008-12-02 JP JP2010537379A patent/JP2011506376A/ja active Pending
- 2008-12-02 CA CA2707132A patent/CA2707132A1/en not_active Abandoned
- 2008-12-02 BR BRPI0820765-8A patent/BRPI0820765A2/pt not_active IP Right Cessation
- 2008-12-08 TW TW097147695A patent/TWI374890B/zh not_active IP Right Cessation
- 2008-12-09 AR ARP080105329A patent/AR069608A1/es not_active Application Discontinuation
- 2008-12-09 PE PE2008002033A patent/PE20091214A1/es not_active Application Discontinuation
- 2008-12-10 CL CL2008003660A patent/CL2008003660A1/es unknown
- 2008-12-11 US US12/316,309 patent/US8227571B2/en not_active Expired - Fee Related
-
2010
- 2010-05-24 IL IL205932A patent/IL205932A0/en unknown
- 2010-05-28 ZA ZA2010/03849A patent/ZA201003849B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20090292108A1 (en) | 2009-11-26 |
CN101903400B (zh) | 2013-12-18 |
ZA201003849B (en) | 2011-04-28 |
AU2008334783A1 (en) | 2009-06-18 |
JP2011506376A (ja) | 2011-03-03 |
WO2009074483A2 (en) | 2009-06-18 |
EP2222695A2 (en) | 2010-09-01 |
CN101903400A (zh) | 2010-12-01 |
US8227571B2 (en) | 2012-07-24 |
WO2009074483A3 (en) | 2010-05-14 |
IL205932A0 (en) | 2010-11-30 |
MX2010006044A (es) | 2010-06-23 |
TWI374890B (en) | 2012-10-21 |
AR069608A1 (es) | 2010-02-03 |
KR20100102652A (ko) | 2010-09-24 |
PE20091214A1 (es) | 2009-08-14 |
CA2707132A1 (en) | 2009-06-18 |
RU2010128247A (ru) | 2012-01-20 |
CL2008003660A1 (es) | 2010-01-04 |
TW200927756A (en) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0820765A2 (pt) | Métodos para a produção de um peptídeo insulinotrópico e peptídeos | |
IL193695A0 (en) | Antibodies against amyloid-beta peptide | |
NO20082895L (no) | Hoytrykks-hoyspenningspenetratorsammensetning | |
IL200478A (en) | Kif20a-derived peptide compounds | |
ZA200905945B (en) | Amino Phosphine | |
BRPI0813858A2 (pt) | Método para produzir peptídeo | |
DK2171053T3 (da) | Natriuretiske polypeptider | |
ATE522545T1 (de) | Amidiertes insulin glargin | |
BRPI0915367A2 (pt) | peptídeos e epítopos anti-p2x7 | |
EP2017283A4 (en) | Peptides | |
BRPI0917564A2 (pt) | bioensaio para proteína poli-q | |
BRPI0814763A2 (pt) | Peptídeos imunomoduladores | |
BRPI0922772A2 (pt) | métodos para selecionar polipeptídeos resistentes a protease | |
GB0723712D0 (en) | Peptides | |
GB0821687D0 (en) | Peptides | |
EP2101804A4 (en) | PRO-ANGIOGENIC PEPTIDES | |
BRPI0917206A2 (pt) | Tablete de liberação prolongada e método para a fabricação e utilização do mesmo | |
IL206013A0 (en) | Stat3 epitope peptides | |
GB0725201D0 (en) | Peptide fusion proteins | |
GB0618748D0 (en) | Peptide | |
GB0703945D0 (en) | Peptide | |
EP2188305A4 (en) | MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS | |
GB0605774D0 (en) | Peptide | |
DK2081952T3 (da) | Peptider | |
BRPI1011474A2 (pt) | peptideos antagonisticos para frizzled-1 e frizzled-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |